GRO-Biotech Events — Week of 11/06
Here are the latest events and opportunities, in the life sciences and beyond!
Wednesday, 11/8 Evolution of Biotech in NYC. Biotech XYZ invites you to attend an upcoming event discussing the growth of biotech in NYC. An expert panel will delve into what stakeholders like CEOs, Government entities, venture capital, et al have been doing to foster growth in NYC. They’ll also be discussing what has been done to-date, but also future plans to support innovation and specifically biotech companies. The conversation will included topics likes laws, regulatory, real estate, investments, collaboration with academic institutions, larger life science companies, other biotech companies and more.
Thursday 11/9 (+ Weekly on Thursday) Starta Fall 2023 Pitch Contests. Join Starta Accelerator for their weekly Fall 2023 Pitch Contests, where founders hone their startups' pitch in front of a panel of judges consisting of VCs, angels ,and industry experts. After the presentations, there will be time for Q&A followed by networking with other frontrunners, entrepreneurs and investors of the NYC startup scene.
Thursday, 11/9 Exploring the Life Sciences Investment Landscape. Join Mintz and Oncology Ventures to explore trends in health care and life sciences investing and connect with investors, emerging companies, and leading LP investors. After the program, enjoy cocktails and hors d'oeuvres as you catch up with colleagues, make new connections, and gain critical industry insights.
Thursday, 11/9 CVC-NY Venture Community Networking Happy Hour. alling all individuals interested in the venture space – entrepreneurs, founders, investors, venture capitalists – Join Columbia Venture Community for the latest installment of their monthly happy hour series - this one with a focus on Web3! As always, you get a drink ticket with your registration.
Thursday, 11/9 Founder-Led Bio NYC Tour. Join Pillar VC and co-hosts for the NYC stop of the Founder-led Bio Tour. This event is a curated evening of networking with founders, PhD students and leaders of the founder-led biotech movement. Please note that space is limited to 150-200 attendees, so apply as soon as possible for an in-person spot!
Tuesday, 11/14 Elevator Pitches for Networking. Join Scismic Job Seeker and career coach Jayne Mattson for a workshop focused on helping you become clearer on who you are and what you’re looking for by developing a 30-second elevator pitch that will attract attention and inspire action. Whether you're a job seeker, entrepreneur, or simply want to improve your self-presentation skills, this event is for you! Don't miss this opportunity to boost your personal brand and stand out from the crowd.
Thursday, 11/16 Unleashing the Power of AI in Biotech. The digital transformation of the field of biotech R&D is accelerating, driven by the integration of artificial intelligence (AI) and machine learning (ML). These technologies are reshaping the way biotech companies approach, analyze, and interpret vast amounts of data, paving the way for more informed decision-making and innovative breakthroughs. However, as AI innovation has been happening so fast, what actions can companies take to keep on top of it all? Join the CEOs of Ganymede, Snthesis, and SciNote for a conversation with experts in the space as they discuss the current landscape of AI use in biotech, best practices and platforms that your team can leverage right now to ready your lab and data for AI/ML, and their predictions of how AI/ML will develop in the biotech industry in the future.
(NEW!) Thursday, 11/16 Navigating Entrepreneurship in Neurotech. In the rapidly evolving landscape of neurotechnology, there is much to explore not only in its astounding developments but also the pivotal steps required to de-risk innovations in this dynamic field. From combatting mental health challenges, to preventing aging and neurodegeneration in patients, what does it take to build a neurotech startup and guarantee success in this field? Learn from rising entrepreneurs in this space about funding and regulatory strategies they've pursued, as well as how they've surpassed challenges in de-risking and obtaining data for their neurotech in a relatively new and evolving environment ripe with ethical considerations.